SCHEMBL1161547

SCHEMBL1161547

NCc1cccc(I)c1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.41
ALDH1A1 P00352 5/20 0.39
TDP1 Q9NUW8 2/20 0.39
TAAR1 Q96RJ0 1/20 0.38
PNMT P11086 1/20 0.35
TLR8 Q9NR97 1/20 0.35
TSHR P16473 3/20 0.35
GPR35 Q9HC97 1/20 0.35
KAT2B Q92831 1/20 0.35
MGMT P16455 1/20 0.34
IDO1 P14902 2/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16953762 0.81 ALDH1A1 (0.39) ALDH1A1TDP1TLR8TSHRGPR35
SCHEMBL1855977 0.81 MGMT (0.43) LOXL2ALDH1A1TDP1TAAR1PNMT
SCHEMBL14054978 0.80 ALDH1A1 (0.52) ALDH1A1TDP1TLR8TSHRGPR35
SCHEMBL4146537 0.78 PNMT (0.53) LOXL2ALDH1A1TDP1TAAR1PNMT
SCHEMBL4274301 0.78 GPR35 (0.56) LOXL2ALDH1A1TDP1TAAR1PNMT
SCHEMBL28108699 0.78 LOXL2 (0.41) LOXL2ALDH1A1TDP1PNMTTSHR
SCHEMBL25231628 0.75 HMGB1 (0.47) LOXL2ALDH1A1TDP1TSHRHPGD
SCHEMBL194253 0.75 TDP1 (0.49) ALDH1A1TDP1TAAR1IDO1HPGD
SCHEMBL28488606 0.75 BID (0.40) ALDH1A1TDP1KAT2B
SCHEMBL30267557 0.75 TDP1 (0.43) ALDH1A1TDP1TLR8TSHRGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011012622-A1 BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS GLAXO GROUP LIMITED (GB) 2011-02-03 WO disclosed